Skip to Main Content

Author Details

Jiaoti Huang
Duke University School of Medicine
2000
294
69
PMIDPaper TitleJournal TitlePublished Year
38084059Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer.Prostate2024
36351060Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.Cancer Res2023
37995683Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.Cancer Cell2023
37725629Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers.PLoS One2023
36945493Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.bioRxiv2023
37012130Erratum to "Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy" [Eur Urol 2022;81(5):446-55].Eur Urol2023
37142586CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.Cell Death Dis2023
37069149Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.Signal Transduct Target Ther2023
36963289Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.Redox Biol2023
36724823Folate receptor-mediated targeted therapy for rheumatoid arthritis by methotrexate-phospholipid complex nano-emulsions.J Drug Target2023
36752189Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.J Pathol2023
36828904Rewiring of the N-Glycome with prostate cancer progression and therapy resistance.NPJ Precis Oncol2023
36629158The role of glutamine metabolism in castration-resistant prostate cancer.Asian J Androl2023
36928314RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.J Clin Invest2023
34815524PCK1 regulates neuroendocrine differentiation in a positive feedback loop of LIF/ZBTB46 signalling in castration-resistant prostate cancer.Br J Cancer2022
35674785Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.Abdom Radiol (NY)2022
35394046Phosphorylated MED1 links transcription recycling and cancer growth.Nucleic Acids Res2022
35419594Correction: Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.Clin Cancer Res2022
36109521Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.Nat Commun2022
35879545Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection.Nat Chem Biol2022
36282986<i>Letter to the Editor:</i> mRNA Vaccines in Urological Malignancies.Hum Gene Ther2022
35879190Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion - Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target Analysis.Eur Urol Oncol2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
35046532Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer.Oncogene2022
35306527Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency.Cell Death Dis2022
35058087Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.Eur Urol2022
35027481Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.Mol Cancer Ther2022
35292724A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.Prostate Cancer Prostatic Dis2022
34675120HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.Mol Cancer Ther2022
34591085A Hybrid Human-Machine Learning Approach for Screening Prostate Biopsies Can Improve Clinical Efficiency Without Compromising Diagnostic Accuracy.Arch Pathol Lab Med2022
34645983Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry.Prostate Cancer Prostatic Dis2022
34643693A pleiotropic ATM variant (rs1800057 C&gt;G) is associated with risk of multiple cancers.Carcinogenesis2022
32286548Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer.Prostate Cancer Prostatic Dis2021
33876838Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.Prostate2021
33849067Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer.Nucleic Acids Res2021
33842835Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms.Precis Clin Med2021
33564069Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation.Oncogene2021
33753479A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.Proc Natl Acad Sci U S A2021
35004332Glycosylation Changes in Prostate Cancer Progression.Front Oncol2021
34591333Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.Prostate2021
34554200Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer.JAMA Oncol2021
34732721Transcription recycling assays identify PAF1 as a driver for RNA Pol II recycling.Nat Commun2021
34799554TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.Oncogenesis2021
33219316Plectin is a regulator of prostate cancer growth and metastasis.Oncogene2021
33398073Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.Commun Biol2021
32763316Urinary Pubic Symphysis Fistula Leads to Histopathologic Osteomyelitis in Prostate Cancer Survivors.Urology2021
32589068The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.Arch Pathol Lab Med2021
32948433Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.Urol Oncol2021
31596671Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men.J Urol2020
31644322Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review.Arch Pathol Lab Med2020
  • 1 - 50 of 294

Recommended Authors

University of British Columbia
Career Start Year 2012
Number of shared co-authors 18
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 23
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 27
University of British Columbia
Career Start Year 2008
Number of shared co-authors 26
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 12
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 8
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 32
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 8
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 8
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 15
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 31
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 8
Northwestern University
Career Start Year 2003
Number of shared co-authors 53
University of British Columbia
Career Start Year 2002
Number of shared co-authors 23
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 28
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 27
Peter MacCallum Cancer Centre
Career Start Year 1999
Number of shared co-authors 9
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 24
University College London
Career Start Year 1999
Number of shared co-authors 7
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 26
Georgetown University
Career Start Year 1993
Number of shared co-authors 4
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 32
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 6
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 41
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 11
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 35
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1987
Number of shared co-authors 25
University of Utah
Career Start Year 1986
Number of shared co-authors 38
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 47

Collaborators

University of California los angeles
Co-authored papers 35
David Geffen School of Medicine at university of california los angeles
Co-authored papers 34
Weill Cornell Medical College
Co-authored papers 32
David Geffen School of Medicine, University of California los angeles
Co-authored papers 20
University of British Columbia
Co-authored papers 19
University of California san francisco
Co-authored papers 18
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 17
University of California San Francisco
Co-authored papers 17
UCSF Medical Center-Mount Zion
Co-authored papers 15
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 15
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 14
University of California San Francisco
Co-authored papers 14
University of California at Santa Cruz
Co-authored papers 13
University of California Davis
Co-authored papers 12
University of California los angeles
Co-authored papers 11
University of California-San Francisco
Co-authored papers 10
University of California los angeles
Co-authored papers 9
University of California Davis Comprehensive Cancer Center
Co-authored papers 9
UF Health Cancer Center
Co-authored papers 7
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Co-authored papers 7
Co-authored papers 7
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 7
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 7
University of British Columbia
Co-authored papers 7
Bluestar Genomics Inc.
Co-authored papers 6
Co-authored papers 6
University of Bern
Co-authored papers 6
Emory University School of Medicine
Co-authored papers 6
University of California San Francisco
Co-authored papers 6
University of British Columbia
Co-authored papers 5